Antibiotic-induced within-host resistance development of gram-negative bacteria in patients receiving selective decontamination or standard care

Critical Care Medicine

Volumn 43, Issue 12, 2015, Pages 2582-2588

  Noteboom, Yvonne ^a   Ong, David S Y ^a   Oostdijk, Evelien A ^a   Schultz, Marcus J ^b   De Jonge, Evert ^c   Purmer, Ilse ^d   Bergmans, Dennis ^e   Fijen, Jan Willem ^f   Kesecioglu, Jozef ^a   Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HAGA HOSPITAL   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

antibacterial agents; drug resistance bacterial; Gram negative bacteria; infection control analysis; intensive care unit

Indexed keywords

CARBAPENEM; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIGESTIVE DECONTAMINATION; DRUG EXPOSURE; DRUG USE; ENTEROBACTER; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; NETHERLANDS; OROPHARYNGEAL DECONTAMINATION; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFECTS; EPIDEMIOLOGY; GASTROINTESTINAL TRACT; INTENSIVE CARE; MICROBIOLOGY; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; OROPHARYNX; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; CRITICAL CARE; CROSS-OVER STUDIES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER; GASTROINTESTINAL TRACT; GRAM-NEGATIVE BACTERIA; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA; NETHERLANDS; OROPHARYNX; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTIONS;

EID: 84947489978     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001298     Document Type: Article

References (24)

1. L'Hériteau F, Alberti C, Cohen Y, Nosocomial infection and multidrug-resistant bacteria surveillance in intensive care units: A survey in France. Infect Control Hosp Epidemiol 2005 26 13 20
2. Burgmann H, Hiesmayr JM, Savey A, Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients. Intensive Care Med 2010 36 1597 1601
3. Vincent JL, Rello J, Marshall J, EPIC II Group of Investigators International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009 302 2323 2329
4. Carmeli Y, Troillet N, Eliopoulos GM, Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999 43 1379 1382
5. Georges B, Conil JM, Dubouix A, Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units. Crit Care Med 2006 34 1636 1641
6. Harbarth S, Harris AD, Carmeli Y, Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001 33 1462 1468
7. Ong DS, Jongerden IP, Buiting AG, Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units. Crit Care Med 2011 39 2458 2463
8. de Jonge E, Schultz MJ, Spanjaard L, Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: A randomised controlled trial. Lancet 2003 362 1011 1016
9. de Smet AM, Kluytmans JA, Cooper BS, Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009 360 20 31
10. de Smet AM, Kluytmans JA, Blok HE, Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: An open-label, clustered group-randomised, crossover study. Lancet Infect Dis 2011 11 372 380
11. D'Amico R, Pifferi S, Leonetti C, Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomised controlled trials. BMJ 1998 316 1275 1285
12. Bergmans DC, Bonten MJ, Gaillard CA, Prevention of ventilator-Associated pneumonia by oral decontamination: A prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001 164 382 388
13. Collard HR, Saint S, Matthay MA, Prevention of ventilator-Associated pneumonia: An evidence-based systematic review. Ann Intern Med 2003 138 494 501
14. Leone M, Albanese J, Antonini F, Long-Term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-Trauma patients. Crit Care Med 2003 31 2090 2095
15. Daneman N, Sarwar S, Fowler RA, SuDDICU Canadian Study Group Effect of selective decontamination on antimicrobial resistance in intensive care units: A systematic review and meta-Analysis. Lancet Infect Dis 2013 13 328 341
16. Ebner W, Kropec-Hübner A, Daschner FD, Bacterial resistance and overgrowth due to selective decontamination of the digestive tract. Eur J Clin Microbiol Infect Dis 2000 19 243 247
17. Bastin AJ, Ryanna KB, Use of selective decontamination of the digestive tract in United Kingdom intensive care units. Anaesthesia 2009 64 46 49
18. Pelupessy I, Bonten MJ, Diekmann O, How to assess the relative importance of different colonization routes of pathogens within hospital settings. Proc Natl Acad Sci U S A 2002 99 5601 5605
19. Nijssen S, Florijn A, Top J, Unnoticed spread of integron-carrying Enterobacteriaceae in intensive care units. Clin Infect Dis 2005 41 1 9
20. Flamm RK, Weaver MK, Thornsberry C, Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother 2004 48 2431 2436
21. Oostdijk EA, Kesecioglu J, Schultz MJ, Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: A randomized clinical trial. JAMA 2014 312 1429 1437
22. Croughs PD, Li B, Hoogkamp-Korstanje JA, Antibiotic Resistance Surveillance Group Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands. Eur J Clin Microbiol Infect Dis 2013 32 283 288
23. Oudhuis GJ, Verbon A, Hoogkamp-Korstanje JA, Susceptibility Surveillance Study Group Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from intensive care units in The Netherlands, 1998-2005. Int J Antimicrob Agents 2008 31 58 63
24. SWAB NethMap 2010-Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Available at: http%3a%2f%2fwww.swab.nl%2fswab%2fcms3.nsf%2fuploads%2f6F9140D61805A468C12577530037D22B%2f%24FILE%2fNethmap-2010-def.pdf. Accessed October 6, 2014